πŸ‡ΊπŸ‡Έ FDA
Patent

US 7608627

6-azaindole compound

granted A61PA61P1/04A61P1/12

Quick answer

US patent 7608627 (6-azaindole compound) held by Takeda Pharmaceutical Company Limited expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P1/04, A61P1/12, A61P1/16, A61P11/00